Aptose Biosciences Inc. (APTOF)
OTCMKTS · Delayed Price · Currency is USD
1.640
+0.040 (2.50%)
At close: Jan 23, 2026
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of $4.2 million as of January 23, 2026. Its market cap has decreased by -71.37% in one year.
Market Cap
4.20M
Enterprise Value
22.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.64
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 34.16M to 4.20M, a decrease of -87.70%. That is a compound annual growth rate of -6.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 4.20M | 6.43% |
| Dec 31, 2025 | 3.95M | -70.97% |
| Dec 31, 2024 | 13.59M | -32.53% |
| Dec 29, 2023 | 20.15M | -62.12% |
| Dec 30, 2022 | 53.19M | -56.27% |
| Dec 31, 2021 | 121.64M | -68.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 6.51M |
| AXIM Biotechnologies | 6.01M |
| Bioxytran | 6.00M |
| Clearside Biomedical | 5.95M |
| Nymox Pharmaceutical | 5.41M |
| BetterLife Pharma | 5.32M |
| Burzynski Research Institute | 5.00M |
| Mosaic ImmunoEngineering | 4.69M |